PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
HLN vs. RDY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between HLN and RDY is 0.19, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.2

Performance

HLN vs. RDY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Haleon plc (HLN) and Dr. Reddy's Laboratories Limited (RDY). The values are adjusted to include any dividend payments, if applicable.

30.00%40.00%50.00%60.00%NovemberDecember2025FebruaryMarchApril
41.80%
38.37%
HLN
RDY

Key characteristics

Sharpe Ratio

HLN:

1.32

RDY:

0.07

Sortino Ratio

HLN:

1.79

RDY:

0.27

Omega Ratio

HLN:

1.26

RDY:

1.03

Calmar Ratio

HLN:

1.68

RDY:

0.07

Martin Ratio

HLN:

4.01

RDY:

0.14

Ulcer Index

HLN:

6.56%

RDY:

12.43%

Daily Std Dev

HLN:

20.06%

RDY:

24.48%

Max Drawdown

HLN:

-24.83%

RDY:

-58.55%

Current Drawdown

HLN:

-4.68%

RDY:

-18.83%

Fundamentals

Market Cap

HLN:

$46.11B

RDY:

$11.39B

EPS

HLN:

$0.41

RDY:

$0.75

PE Ratio

HLN:

24.93

RDY:

18.23

PEG Ratio

HLN:

1.80

RDY:

4.51

PS Ratio

HLN:

4.10

RDY:

0.04

PB Ratio

HLN:

2.16

RDY:

3.07

Total Revenue (TTM)

HLN:

$8.31B

RDY:

$240.48B

Gross Profit (TTM)

HLN:

$5.20B

RDY:

$143.17B

EBITDA (TTM)

HLN:

$1.73B

RDY:

$69.94B

Returns By Period

In the year-to-date period, HLN achieves a 6.81% return, which is significantly higher than RDY's -13.43% return.


HLN

YTD

6.81%

1M

-0.88%

6M

2.10%

1Y

24.64%

5Y*

N/A

10Y*

N/A

RDY

YTD

-13.43%

1M

-0.29%

6M

-13.20%

1Y

2.04%

5Y*

8.66%

10Y*

4.31%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

HLN vs. RDY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HLN
The Risk-Adjusted Performance Rank of HLN is 8787
Overall Rank
The Sharpe Ratio Rank of HLN is 9090
Sharpe Ratio Rank
The Sortino Ratio Rank of HLN is 8484
Sortino Ratio Rank
The Omega Ratio Rank of HLN is 8585
Omega Ratio Rank
The Calmar Ratio Rank of HLN is 9292
Calmar Ratio Rank
The Martin Ratio Rank of HLN is 8585
Martin Ratio Rank

RDY
The Risk-Adjusted Performance Rank of RDY is 5353
Overall Rank
The Sharpe Ratio Rank of RDY is 5757
Sharpe Ratio Rank
The Sortino Ratio Rank of RDY is 4848
Sortino Ratio Rank
The Omega Ratio Rank of RDY is 4848
Omega Ratio Rank
The Calmar Ratio Rank of RDY is 5757
Calmar Ratio Rank
The Martin Ratio Rank of RDY is 5656
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

HLN vs. RDY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Haleon plc (HLN) and Dr. Reddy's Laboratories Limited (RDY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for HLN, currently valued at 1.32, compared to the broader market-2.00-1.000.001.002.003.00
HLN: 1.32
RDY: 0.07
The chart of Sortino ratio for HLN, currently valued at 1.79, compared to the broader market-6.00-4.00-2.000.002.004.00
HLN: 1.79
RDY: 0.27
The chart of Omega ratio for HLN, currently valued at 1.26, compared to the broader market0.501.001.502.00
HLN: 1.26
RDY: 1.03
The chart of Calmar ratio for HLN, currently valued at 1.68, compared to the broader market0.001.002.003.004.00
HLN: 1.68
RDY: 0.07
The chart of Martin ratio for HLN, currently valued at 4.01, compared to the broader market-5.000.005.0010.0015.0020.00
HLN: 4.01
RDY: 0.14

The current HLN Sharpe Ratio is 1.32, which is higher than the RDY Sharpe Ratio of 0.07. The chart below compares the historical Sharpe Ratios of HLN and RDY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.50NovemberDecember2025FebruaryMarchApril
1.32
0.07
HLN
RDY

Dividends

HLN vs. RDY - Dividend Comparison

HLN's dividend yield for the trailing twelve months is around 0.50%, less than RDY's 4.21% yield.


TTM20242023202220212020201920182017201620152014
HLN
Haleon plc
0.50%1.65%1.26%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
RDY
Dr. Reddy's Laboratories Limited
4.21%3.64%1.39%1.48%0.52%0.46%0.70%0.77%0.83%0.66%0.67%0.58%

Drawdowns

HLN vs. RDY - Drawdown Comparison

The maximum HLN drawdown since its inception was -24.83%, smaller than the maximum RDY drawdown of -58.55%. Use the drawdown chart below to compare losses from any high point for HLN and RDY. For additional features, visit the drawdowns tool.


-25.00%-20.00%-15.00%-10.00%-5.00%0.00%NovemberDecember2025FebruaryMarchApril
-4.68%
-18.83%
HLN
RDY

Volatility

HLN vs. RDY - Volatility Comparison

Haleon plc (HLN) has a higher volatility of 11.13% compared to Dr. Reddy's Laboratories Limited (RDY) at 10.51%. This indicates that HLN's price experiences larger fluctuations and is considered to be riskier than RDY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%NovemberDecember2025FebruaryMarchApril
11.13%
10.51%
HLN
RDY

Financials

HLN vs. RDY - Financials Comparison

This section allows you to compare key financial metrics between Haleon plc and Dr. Reddy's Laboratories Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab